Telix Pharma
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
ProstACT Update: TARGET Study Ethics Approval 2022-04-12 07:47
Telix Pharmaceuticals Announces Licence Agreement with Lilly for Olaratumab 2022-04-11 06:51
PSMA-PET Imaging to be Funded through Medicare in Australia from July 2022 2022-04-06 12:47
Telix, GMS and Monash Awarded $23M Federal Government Funding as part of $71M Australian Precision Medicine Enterprise (APME) Project 2022-04-04 09:13
Commercial Launch: Illuccix® Now Available to Order in the United States 2022-04-04 07:06
Change of Composition of the Telix Board of Directors 2022-03-31 07:11
New Video Series "PSMA PET/CT TODAY" Discusses the Future of Prostate Cancer Care with Leading Experts 2022-03-29 19:00
Telix Granted FDA Orphan Drug Designation for Bone Marrow Conditioning Treatment 2022-03-29 13:34
Telix and Xiel Sign U.K. and Ireland Distribution Agreement for Illuccix® 2022-03-29 07:39
Telix Advances Development of Glioblastoma Therapy Program 2022-03-23 10:16
1 3 4 5 6 7